Learn why this royalty company believes it is the best way to play commodities and inflation. on 06/08/2021. Learn More

Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe

News Update


Cannabis Cultivator Shifts Focus to Commercializing Technology
News Update

Share on Stocktwits


Sproutly Canada has received capital investment from Infusion Biosciences.

Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB) is shifting its strategy toward commercializing its proprietary APP Technology and away from cultivating cannabis, it announced in a news release.

The goal is to transform Sproutly into an "'asset light' technology model focused on generating revenues via technology licensing, ingredient supply agreements and partnership opportunities," the release explained. The firm would achieve this by leveraging the existing infrastructure and distribution networks of licensed producers selling its cannabis 2.0 products in Canada similar products elsewhere.

"This business transformation is yet another step towards streamlining our strategy to focus on the technology and what sets us apart," said Keith Dolo, who has stepped down as Sproutly's CEO and board member to be the strategic adviser to the board chairman.

The company already made a number of changes. To reduce cash burn, it significantly scaled back its cannabis growing component, which became cost prohibitive. It began cutting costs, like reducing its staff by about 75%.

Also, Sproutly appointed its chief science officer, Dr. Arup Sen, as the company CEO to carry out the business transformation plan. Sen also is the inventor of the APP technology and the CEO of Infusion Biosciences. Infusion Biosciences, Sproutly's largest shareholder, committed to investing up to an additional $855,000 in the company.

As for its beverage agreement with Moosehead Brewing, Sproutly is continuing discussions with the company about changing their 50/50 joint venture to a nonexclusive licensing or supply agreement for Infuz2O. This would benefit Sproutly in various ways, such as eliminating its need to invest further capital, diversifying its customer base and adding possible revenue streams.

With respect to its cultivation facility, Sproutly is looking into its options in that regard, including selling it.


1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: Sproutly Canada. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this interview, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Sproutly Canada, a company mentioned in this article.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

Want to read more about Cannabis and Nutraceuticals investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe